| Literature DB >> 33517524 |
Hannah Voß1, Peter Scholz-Kreisel2, Christoph Richter1, Florian Ringel1, Susanne Singer2, Mirjam Renovanz3,4.
Abstract
PURPOSE: Psychosocial screening for glioma patients is challenging because many patients suffer from neurocognitive deficits, which may impair assessment. This study's aim was to exploratively develop three screening questions for unmet needs to prospectively be applicable in patient-doctor consultation.Entities:
Keywords: Brain tumor; Distress; Glioma; Neurooncology; Quality of life; Screening
Mesh:
Year: 2021 PMID: 33517524 PMCID: PMC8068662 DOI: 10.1007/s11136-021-02756-x
Source DB: PubMed Journal: Qual Life Res ISSN: 0962-9343 Impact factor: 4.147
Fig. 1Study design and workflow
Fig. 2Weighted scoring procedure
Patient sample
| Variable | %100 | |
|---|---|---|
| Age | ||
| Mean (SD, range) | 56 (13, 30–79) | |
| Gender | ||
| Male | 35 | 70 |
| Female | 15 | 30 |
| Family situation | ||
| Married/ in a relationship | 38 | 76 |
| Divorced | 4 | 8 |
| Widowed | 1 | 2 |
| Single | 7 | 14 |
| Living situation | ||
| Living alone | 10 | 20 |
| Living with others | 40 | 80 |
| Working situation | ||
| Employed | 12 | 24 |
| Disability pension | 22 | 44 |
| Retirement pension | 14 | 28 |
| Homemaker | 2 | 4 |
| Graduation | ||
| Lower secondary school | 11 | 22 |
| Intermediate secondary school | 20 | 40 |
| High school | 19 | 38 |
| Religion | ||
| None | 10 | 20 |
| Evangelic | 24 | 48 |
| Catholic | 13 | 26 |
| Muslim | 1 | 2 |
| Free Church | 1 | 2 |
| Other | 1 | 2 |
| Side of tumor | ||
| Right | 21 | 42 |
| Left | 17 | 34 |
| Midline | 5 | 10 |
| Multifocal | 7 | 14 |
| Last tumor resection prior to interview | ||
| Gross total resection | 37 | 74 |
| Sub total resection | 8 | 16 |
| Biopsy | 5 | 10 |
| Chemotherapy during the last six weeks prior to the Interview | ||
| No | 30 | 60 |
| Yes | 20 | 40 |
| Histopathology | ||
| Glioblastoma, WHO Grade IV, IDH wildtype | 23 | 46 |
| Astrocytoma, WHO Grade III, IDH wildtype | 3 | 6 |
| Astrocytoma, WHO Grade III, IDH mutated | 12 | 24 |
| Astrocytoma, WHO Grade II, IDH mutated | 2 | 4 |
| Anaplastic Oligoastrocytomaa, NOS | 3 | 6 |
| Oligodendroglioma, WHO Grade III, IDH mutated | 5 | 10 |
| Ependymoma WHO Grade II | 2 | 4 |
| Localization of the tumor | ||
| Frontal | 15 | 30 |
| Occipital | 3 | 6 |
| Parietal | 9 | 18 |
| Temporal | 12 | 24 |
| Others | 11 | 22 |
| Disease stage | ||
| First diagnosis | 31 | 62 |
| Recurrence | 19 | 38 |
| Karnofsky performance score | ||
| ≥ 70 | 42 | 84 |
| < 70 | 8 | 16 |
| ECOG performance score | ||
| 0 | 13 | 26 |
| 1 | 22 | 44 |
| 2 | 15 | 30 |
| Household net income in €/month | ||
| Mean (SD, range) | 2487.34 (1782.6; 400–8000) | |
| Time since diagnosis (months) | ||
| Mean (SD, range) | 62 (93; 0.7–369) | |
| Age at diagnosis (years) | ||
| Mean (SD, range) | 51 (16; 12–78) | |
aSurgery before WHO 2016
Final values of the areas after the weighted scoring procedure
| Area | Final value (joint) | Patients only (step C of the scoring procedure) | Health-care professionals only (step F of the scoring procedure) |
|---|---|---|---|
| Psyche | 21.2 | 14.0 | |
| 23.9 | 21.0 | ||
| 21.1 | 22.0 | ||
| Role functioning | 18.3 | 21.4 | 12.2 |
| Social support | 17.2 | 19.2 | 13.2 |
| Unmet needs | 15.5 | 18.0 | 10.4 |
| Unmet needs calculated only with the top 5 itemsa | 16.9 | 19.7 | 11.4 |
Bold values indicate most important areas according weighted scoring procedure
aThe additional calculation was done because more precise selection of items for the interview considering literature could be done for the other areas compared to the area “unmet” needs”. To avoid that “unmet needs” had the lowest final value because of lesser item selection, it was calculated again using only the top 5 items of our patient and health-care professionals’ sample